Analysis

Constellation Brands’ (STZ) beer business remains resilient in a tough environment

Shares of Constellation Brands, Inc. (NYSE: STZ) gained 1% on Friday. The stock has dropped 4% over the past three months. The

What to look for when Charles Schwab (SCHW) reports Q3 2024 results

Financial services company The Charles Schwab Corporation (NYSE: SCHW) is preparing to report third-quarter results on October 14, with experts predicting a

After a weak start to FY25, Conagra Brands (CAG) reaffirms full-year guidance

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer-packaged goods, reported weaker-than-expected first-quarter results this week, with customers becoming increasingly budget-conscious

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

KinderCare Learning Companies to offer 24 Mln shares for $23-27 in US IPO

In 2024, the IPO market shifted to recovery mode, with a significant increase in activity compared to last year when it witnessed a slowdown. Encouraged by the booming stock market

October 4, 2024

Constellation Brands’ (STZ) beer business remains resilient in a tough environment

Shares of Constellation Brands, Inc. (NYSE: STZ) gained 1% on Friday. The stock has dropped 4% over the past three months. The beverages giant delivered better-than-expected earnings results for the

October 4, 2024

What to look for when Charles Schwab (SCHW) reports Q3 2024 results

Financial services company The Charles Schwab Corporation (NYSE: SCHW) is preparing to report third-quarter results on October 14, with experts predicting a mixed outcome. As part of its long-term succession

October 4, 2024

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top